TXN, a redox-active protein induced by diverse cellular stresses, has demonstrated therapeutic efficacy in various inflammatory disease models, including viral pneumonia, acute lung injury, gastric injury, dermatitis, and others [32]. The gene discussed is TXN; the disease is viral pneumonia.